Last updated: June 1, 2026
Suppliers for OSMITROL 20% IN WATER (Osmitrol, ioversol aqueous 20%): Who sells it and where is supply concentrated?
OSMITROL 20% IN WATER is an aqueous iodinated contrast medium marketed under the Osmitrol brand name. The product is supplied through the pharmaceutical distribution and specialty chemical/contrast media supply chain rather than as a typical “small-molecule generic” with broad retail availability.
Bottom line: Suppliers for Osmitrol 20% in Water are the brand’s authorized distributors and specialty contrast-media wholesalers in each target market, with manufacturing typically done by the underlying contrast-media manufacturer(s) and sold through regional license/distribution agreements.
Because “OSMITROL 20% IN WATER” can appear under different local labels, pack sizes, and national registries, supplier identification requires mapping to the specific country’s product listing and its marketing authorization holder and/or MAH.
No source material was provided in the prompt to anchor the supplier list to specific jurisdictions, pack presentations, or FDA/EMA/Orange Book/NDC or local marketing authorization records. Without that anchoring data, producing a complete, accurate, and citation-backed supplier list would risk listing incorrect entities.
Which companies supply Osmitrol 20% in water by region?
Answer: The supply is split between (1) the manufacturing entity behind the iodinated contrast medium and (2) the authorized distributors/wholesalers that import and sell the brand in each country. The exact supplier set varies by jurisdiction and tender/contracting structure.
US-focused supplier mapping
If the product is marketed in the US, the practical supplier “who to call” list is typically pulled from:
- the NDC labeler/distributor,
- the Drug Listing file (FDA),
- and purchasing/tender records for radiology services.
EU-focused supplier mapping
In the EU, mapping usually uses:
- national product marketing authorization listings,
- the MAH name,
- and local importers/distributors.
Rest-of-world (ROW)
In many ROW markets, supply comes through:
- hospital procurement distributors,
- contrast-media importers,
- and government tender contracts.
Is Osmitrol 20% in water made by one manufacturer or multiple contract manufacturers?
Answer: Iodinated contrast media are frequently produced under controlled batch manufacturing by a limited number of contrast-media manufacturers, then distributed via regional licensing and distribution partners. Multiple sources can exist for packaging and labeling, but manufacturing is generally concentrated.
Common supply chain pattern for contrast media
- Bulk manufacture of iodinated solution
- Aseptic filling and packaging (sometimes in the same facility, sometimes contract-filled)
- Labeling under regional brand presentation
- Distribution via specialty wholesalers
What active ingredient is in Osmitrol 20% in water, and does that change supplier eligibility?
Answer: The supplier list for a branded product is often constrained by the labeled concentration and formulation. If “Osmitrol 20% in water” corresponds to a specific iodinated agent/concentration (brand-to-API mapping), supplier qualification depends on the same labeled composition.
Why this matters for “supplier” searches
Many databases index suppliers by:
- brand name,
- dosage form,
- concentration,
- and labeler/MAH.
Even when the API is the same across brands, “supplier” outcomes differ by labeled presentation.
What are the main procurement channels for Osmitrol 20% in water?
Answer: The highest-volume routes are specialty pharmaceutical distributors and hospital group purchasing organizations. For iodinated contrast media, supply chain continuity also depends on:
- tender cycles,
- cold-chain requirements (if any, depending on local handling guidance),
- and reimbursement/formulary inclusion.
Typical channels
- Hospital procurement tenders (single-source or contract bundles)
- Specialty wholesalers supplying radiology departments
- Direct distribution from MAH/distributor to group purchasing organizations
What patent or regulatory status affects who can supply Osmitrol 20% in water?
Answer: For contrast media, “supplier” constraints are driven more by regulatory marketing authorization and GMP manufacturing capacity than by “patent barriers” in the conventional small-molecule generic sense.
Regulatory gating factors that determine suppliers
- Marketing authorization (MAH) for the specific presentation
- GMP manufacturing and release site approval
- Importer/distributor authorization (country-specific)
- Pharmacovigilance agreement participation
Key Takeaways
- Osmitrol 20% in water is supplied via authorized manufacturing and regional distribution channels, with supplier identity varying by country and label presentation.
- Practical supplier identification requires tying the brand to its jurisdiction-specific MAH/labeler and NDC or national authorization listing.
- Without the country-specific product registry anchor, generating a definitive supplier roster would risk inaccuracies.
FAQs
-
How do I find the MAH/labeler for Osmitrol 20% in water in my country?
Use the national drug registration or labeler database for the exact brand, strength, and dosage form.
-
Are Osmitrol 20% in water suppliers different for hospital tenders vs retail?
Yes, hospital supply is commonly routed through specialty wholesalers and tender-contract distributors.
-
Can multiple distributors supply the same Osmitrol presentation?
Yes, where multiple authorized wholesalers import and distribute the same MAH-labeled product.
-
Do generics exist for Osmitrol 20% in water?
In iodinated contrast media, equivalents may exist, but “brand-to-equivalent” mapping depends on the exact iodinated agent and concentration, and on regulatory authorization in the market.
-
What affects supply availability most for iodinated contrast media?
Manufacturing capacity, batch release capacity, and regulatory distribution authorization drive availability more than typical patent status.
References
No sources were provided in the prompt to cite.
